Innovent/GenFleet Score China’s First KRAS G12C Inhibitor Approval

Homegrown Competition Looming

 
• By Dexter Jie Yan
  
first to hit the line
Innovent/GenFlee hit finish line for China's first approved KRAS G12C inhibitor • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia